Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 
 Washington, D.C. 20549
_______________
 
FORM 10-Q
 
(Mark One)	
 x	     	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
 	 	 	
    For the quarterly period ended December 31, 2011.	
 	
OR	
 o	 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
 
    For the transition period from               to
 
Commission File Number: 1-07151
_______________
 
THE CLOROX COMPANY
 (Exact name of registrant as specified in its charter)
 
Delaware	     	31-0595760	
(State or other jurisdiction of	 	(I.R.S. Employer Identification No.)	
incorporation or organization)	 	 	
 	 	 	
1221 Broadway	 	 	
Oakland, California	 	94612-1888	
(Address of principal executive offices)	 	(Zip code)	
 
(510) 271-7000	
(Registrant's telephone number, including area code)	
 	
(Former name, former address and former fiscal year, if changed since last report)
________________	
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  þ   No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes  þ   No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer, ” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
 
Large accelerated filer þ	     	Accelerated filer o	     	Non-accelerated filer o	     	Smaller Reporting Company o	
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes o   No þ

As of January 31 , 2012, there were 129,802,146 shares outstanding of the registrant's common stock ($1.00 - par value) .

 

Table of Contents
The Clorox Company
	Page
No.	
PART I. Financial Information	       3	  	
       Item 1. Financial Statements	3		
              Condensed Consolidated Statements of Earnings for the Three and Six Months Ended			
                     December 31, 2011 and 2010	3		
              Condensed Consolidated Balance Sheets at December 31, 2011 and June 30, 2011	4		
              Condensed Consolidated Statements of Cash Flows for the Six Months Ended			
                     December 31, 2011 and 2010	5		
              Notes to Condensed Consolidated Financial Statements	6		
       Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	15		
       Item 3. Quantitative and Qualitative Disclosure about Market Risk	26		
       Item 4. Controls and Procedures	26		
PART II. Other Information	27		
       Item 1.A. Risk Factors	27		
       Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	27		
       Item 5. Other Information	27		
       Item 6. Exhibits	28		

2

Table of Contents
 PART I – FINANCIAL   INFORMATION
 Item 1. Financial Statements
 The Clorox Company
 Condensed Consolidated Statements of Earnings (Unaudited)
(Dollars in millions, except per share amounts)

		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
Net sales	     	$    	1,221		     	$    	1,179		     	$    	2,526		     	$    	2,445		
Cost of products sold			714				687				1,473				1,392		
Gross profit			507				492				1,053				1,053		
 	
Selling and administrative expenses			184				180				374				361		
Advertising costs			115				117				233				235		
Research and development costs			29				28				57				57		
Goodwill impairment			-				258				-				258		
Interest expense			30				33				59				65		
Other income, net			(6	)			(12	)			(12	)			(13	)	
Earnings (losses) from continuing operations before income taxes			155				(112	)			342				90		
Income taxes on continuing operations			50				51				107				113		
Earnings (losses) from continuing operations			105				(163	)			235				(23	)	
Discontinued operations:																	
       Earnings from Auto businesses, net of tax			-				7				-				23		
       Gain on sale of Auto businesses, net of tax			-				177				-				237		
Earnings from discontinued operations			-				184				-				260		
Net earnings		$	105			$	21			$	235			$	237		
 	
Earnings (losses) per share																	
       Basic																	
              Continuing operations		$	0.79			$	(1.17	)		$	1.78			$	(0.17	)	
              Discontinued operations			-				1.32				-				1.87	 	
       Basic net earnings per share		$	0.79			$	0.15			$	1.78			$	1.70		
 	
       Diluted																	
              Continuing operations		$	0.79			$	(1.17	)		$	1.76			$	(0.17	)	
              Discontinued operations			-				1.32				-				1.87		
       Diluted net earnings per share		$	0.79			$	0.15			$	1.76			$	1.70		
 	
Weighted average shares outstanding (in thousands)																	
       Basic			131,112			 	138,678	 		 	131,540			 	139,077		
       Diluted			132,358	 			138,678				133,022	 			139,077		
 	
Dividend declared per share		$	0.60			$	0.55			$	1.20			$	1.10		

See Notes to Condensed Consolidated Financial Statements
3

Table of Contents
The Clorox Company
 Condensed Consolidated Balance Sheets
(Dollars in millions, except per share amounts)

	12/31/2011	     	6/30/2011	
	(Unaudited)					
ASSETS								
Current assets								
       Cash and cash equivalents	$    	297			$    	259		
       Receivables, net		489				525		
       Inventories, net		451				382		
       Other current assets		111				113		
              Total current assets		1,348				1,279		
Property, plant and equipment, net		1,041				1,039		
Goodwill		1,093				1,070		
Trademarks, net		566				550		
Other intangible assets, net		103				83		
Other assets		139				142		
Total assets	$	4,290			$	4,163		
 	
LIABILITIES AND STOCKHOLDERS’ DEFICIT								
Current liabilities								
       Notes and loans payable	$	476			$	459		
       Current maturities of long-term debt		350				-		
       Accounts payable		345				423		
       Accrued liabilities		438				442		
       Income taxes payable		28				41		
              Total current liabilities		1,637				1,365		
Long-term debt		2,070				2,125		
Other liabilities		641				619		
Deferred income taxes		141				140		
              Total liabilities		4,489				4,249		
 	
Contingencies								
 	
Stockholders’ deficit								
Preferred stock: $0.001 par value; 5,000,000 shares authorized;								
       none issued or outstanding		-				-		
Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares								
       issued at December 31, 2011 and June 30, 2011; and 129,694,049 and 131,066,864								
       shares outstanding at December 31, 2011 and June 30, 2011, respectively		159				159		
Additional paid-in capital		616				632		
Retained earnings		1,210				1,143		
Treasury shares, at cost: 29,047,412 and 27,674,597 shares at December 31, 2011		 	 					
       and June 30, 2011, respectively		(1,861	)			(1,770	)	
Accumulated other comprehensive net losses	 	(323	)		 	(250	)	
Stockholders’ deficit		(199	)			(86	)	
Total liabilities and stockholders’ deficit	$	4,290			$	4,163		

See Notes to Condensed Consolidated Financial Statements
4

Table of Contents
The Clorox Company
  Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollars in millions)

		Six Months Ended	
	     	12/31/2011	     	12/31/2010	
Operating activities:									
       Net earnings		$    	235			$    	237		
       Deduct: Earnings from discontinued operations			-				260		
       Earnings (losses) from continuing operations			235				(23	)	
       Adjustments to reconcile earnings (losses) from continuing operations									
              to net cash provided by operations:									
                     Depreciation and amortization			89				88		
                     Share-based compensation			11				14		
                     Deferred income taxes			3				7		
                     Goodwill impairment			-				258		
                     Net gain on disposition of assets			(1	)			(19	)	
                     Other			8				19		
                     Changes in:									
                            Receivables, net			35				54		
                            Inventories, net			(65	)			(68	)	
                            Other current assets			-				17		
                            Accounts payable and accrued liabilities			(136	)			(129	)	
                            Income taxes payable			(11	)			(48	)	
Net cash provided by continuing operations			168				170		
Net cash provided by discontinued operations			-				55		
Net cash provided by operations			168				225		
Investing activities:									
       Capital expenditures			(82	)			(89	)	
       Proceeds from sale of businesses, net of transaction costs			-				747		
       Businesses acquired			(85	)			-		
       Other			4				25		
Net cash (used for) provided by investing activities			(163	)			683		
Financing activities:									
       Notes and loans payable, net			14				(369	)	
       Long-term debt borrowings, net of issuance costs			297				-		
       Treasury stock purchased			(158	)			(134	)	
       Cash dividends paid			(159	)			(154	)	
       Issuance of common stock for employee stock plans and other			44				35		
Net cash provided by (used for) financing activities			38				(622	)	
Effect of exchange rate changes on cash and cash equivalents	 		(5	)			6	 	
Net increase in cash and cash equivalents			38				292		
Cash and cash equivalents:		 		 	 				
Beginning of period			259			 	87		
End of period		$	297			$	379		

See Notes to Condensed Consolidated Financial Statements
5

Table of Contents
 Notes to Condensed Consolidated Financial Statements
The Clorox Company
(Dollars in millions, except per share amounts)
NOTE 1. INTERIM FINANCIAL STATEMENTS
Basis of Presentation
The unaudited interim condensed consolidated financial statements for the three and six months ended December 31, 2011 and 2010, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its subsidiaries (the Company) for the periods presented. The results for the interim period ended December 31, 2011, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2012, or for any future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended June 30, 2011, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ materially from estimates and assumptions made.
Recently Issued Accounting Pronouncements
On September 15, 2011, the Financial Accounting Standards Board (FASB) issued new guidance to simplify how entities test for goodwill impairment. The new guidance allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. The new guidance is effective for the annual goodwill impairment test to be performed in fiscal year 2013, with early adoption permitted. The Company is currently evaluating the anticipated timing for its adoption.
NOTE 2. BUSINESSES ACQUIRED
On December 31, 2011, the Company acquired HealthLink, Inc., Aplicare, Inc. and Soy Vay Enterprises, Inc. for purchase prices aggregating $97. The Company paid $85 in December 2011 , funded through commercial paper borrowings. The amount paid reflects the aggregate purchase prices reduced by the cash acquired and amounts to be paid by the Company pending final cash settlements. HealthLink, based in Jacksonville, Fla., and Aplicare, based in Meriden, Conn., are leading providers of infection control products for the health care industry, complementing and expanding the Company’s Away From Home health care business. Results for these businesses will be reflected in the Cleaning reportable segment. Soy Vay Enterprises, a California-based operation, provides the Company’s Food business a presence in the growing market for Asian sauces. Results for this business will be reflected in the Lifestyle reportable segment.
Due to the timing of these acquisitions, the purchase accounting is preliminary and subject to certain closing adjustments, which are not expected to be material. Pro forma results reflecting the acquisitions are not presented because the acquisitions are not significant individually, or when aggregated, to the Company’s consolidated financial results.
6

Table of Contents
NOTE 3. INVENTORIES, NET
Inventories, net, consisted of the following as of:

	     	12/31/2011	     	6/30/2011	
Finished goods		$    	377			$    	315		
Raw materials and packaging			121				104		
Work in process			3				3		
LIFO allowances		 	(38	)		 	(29	)	
Allowances for obsolescence			(12	)			(11	)	
Total		$	451			$	382		

NOTE 4. OTHER LIABILITIES
Other liabilities consisted of the following as of:

	12/31/2011		6/30/2011	
Venture agreement net terminal obligation	$    	279	     	$    	277	
Employee benefit obligations		220		 	215	
Taxes		93			89	
Other	 	49			38	
Total	$	641		$	619	

NOTE 5. DEBT
In November 2011, the Company filed a new shelf registration statement with the SEC, which allows the Company to offer and sell an unlimited amount of its senior unsecured indebtedness from time to time. The shelf registration statement will expire in November 2014. Subsequently, the Company issued $300 of senior notes (notes) under the new shelf registration statement. The notes carry an annual fixed interest rate of 3.80% payable semi-annually in May and November. The notes mature on November 15, 2021. Proceeds from the notes were used to retire commercial paper. The notes rank equally with all of the Company’s existing and future senior indebtedness.
NOTE 6. NET EARNINGS PER SHARE
The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:

	     	Three Months Ended	     	Six Months Ended	
		12/31/2011	     	12/31/2010		12/31/2011	     	12/31/2010	
Basic	 	131,112		138,678		131,540	 	139,077	
Dilutive effect of stock options and other		1,246	 	-	 	1,482		-	
Diluted		132,358		138,678		133,022		139,077	

During the three and six months ended December 31, 2011, the Company did not include stock options to purchase approximately 3.8 million shares and 1.9 million shares, respectively, of the Company’s common stock in the calculations of diluted net EPS because their exercise price was greater than the average market price, making them anti-dilutive.
7

Table of Contents
NOTE 6. NET EARNINGS PER SHARE (Continued)
Since the Company experienced losses from continuing operations for both the three and six months ended December 31, 2010, no dilution was applied to the Company’s basic weighted average shares outstanding for those periods, as to do so would have reduced the Company’s reported losses per share from continuing operations for those periods.
Share repurchases under authorized programs were as follows:

		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
		Amount		Shares
(000)		Amount		Shares
(000)		Amount		Shares
(000)		Amount		Shares
(000)	
Open-market purchase programs	     	$    	149	     	    2,300	     	$    	-	     	-	     	$    	158	     	    2,429	     	$    	-	     	-	
Evergreen Program		 	-	 	-		 	130	 	    2,063		 	-		-		 	134		    2,121	
Total		$	149		2,300		$	130		2,063		$	158		2,429		$	134		2,121	

The purpose of the Evergreen Program is to offset the impact of share dilution related to share-based awards.
NOTE 7. COMPREHENSIVE INCOME
Comprehensive income includes net earnings and certain adjustments that are excluded from net earnings, but included as a separate component of stockholders’ deficit, net of tax. Comprehensive income was as follows:

		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
Earnings (losses) from continuing operations	     	$    	105		     	$    	(163	)	     	$    	235		     	$    	(23	)	
Earnings from discontinued operations			-				184			 	-	 			260		
Net earnings			105	 		 	21				235				237	 	
Other comprehensive income, net of tax:							 										
       Foreign currency translation		 	2				8	 			(37	)			42		
       Net derivative adjustments			(12	)			8				(35	)			6		
       Pension and postretirement benefit adjustments			1				3				(1	)			5		
Total		$	96			$	40			$	162			$	290		

NOTE 8. INCOME TAXES
In determining its quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter. The effective tax rate on earnings (losses) from continuing operations was 32.4% and 31.3% for the three and six months ended December 31, 2011, respectively, and (45.0)% and 125.9% for the three and six months ended December 31, 2010, respectively. The tax rates for the three and six months ended December 31, 2011 include tax benefits associated with foreign earnings and from favorable tax settlements. The substantially different tax rates for the three and six months ended December 31, 2010 resulted from the non-deductible non-cash goodwill impairment charge of $258 related to the Burt’s Bees reporting unit as there was no substantial tax benefit associated with this non-cash charge.
The balance of unrecognized tax benefits at December 31, 2011 and June 30, 2011, includes potential benefits of $64 and $68, respectively, which, if recognized, would affect the effective tax rate on earnings.
8

Table of Contents
NOTE 8. INCOME TAXES (Continued)
The Company recognizes interest and penalties related to uncertain tax positions as a component of income tax expense. As of December 31, 2011 and June 30, 2011, the total balance of accrued interest and penalties related to uncertain tax positions was $7 and $8, respectively. Interest and penalties included in income tax expense were net benefits of $0 and $3 for the three and six months ended December 31, 2011, respectively, and net benefits of $1 and $3 for the three and six months ended December 31, 2010, respectively.
The Company files income tax returns in the U.S. federal and various state, local and foreign jurisdictions. The federal statute of limitations has expired for all tax years through June 30, 2007. Various income tax returns in state and foreign jurisdictions are currently in the process of examination.
NOTE 9. RETIREMENT INCOME AND HEALTH CARE BENEFIT PLANS
The following table summarizes the components of net periodic benefit cost for the Company’s retirement income plan:

		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
Service cost	     	$    	-		     	$    	4		     	$    	1		     	$    	7	 	
Interest cost			7				7	 			14				14		
Expected return on plan assets			(7	)		 	(8	)			(15	)			(16	)	
Amortization of unrecognized items		 	2				4			 	4			 	8		
Total		$	2			$	7			$	4			$	13		

The net periodic benefit cost for the Company’s retirement health care plans was less than $1 for both the three and six months ended December 31, 2011, and $1 and $2 for the three and six months ended December 31, 2010, respectively.
NOTE 10. CONTINGENCIES AND GUARANTEES
Contingencies
The Company is involved in certain environmental matters, including Superfund and other response actions at various locations. The Company had a recorded liability of $15 at both December 31, 2011 and June 30, 2011, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson County, Michigan, for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability at both December 31, 2011 and June 30, 2011. The Company has agreed to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company cannot accurately predict the timing of future payments that may be made under this obligation. In addition, the Company’s estimated loss exposure is sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes in remediation requirements and the timing, varying costs and alternative clean-up technologies that may become available in the future. Although it is possible that the Company’s exposure may exceed the amount recorded, any amount of such additional exposures, or range of exposures, is not estimable at this time.
The Company is subject to various other lawsuits and claims relating to issues such as contract disputes, product liability, patents and trademarks, advertising, and employee and other matters. Based on the Company’s analysis of these claims and litigation, it is the opinion of management that the ultimate disposition of these matters, including the environmental matter described above, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on the Company’s consolidated financial statements taken as a whole.
9

Table of Contents
NOTE 10. CONTINGENCIES AND GUARANTEES (Continued)
Guarantees
In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) for which terms vary in duration and potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make any payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material effect on its financial position, results of operations or cash flows, either individually or in the aggregate.
At December 31, 2011, the Company was a party to letters of credit of $15, primarily related to one of its insurance carriers.
The Company had not recorded any liabilities on any of the aforementioned guarantees at December 31, 2011.
NOTE 11. SEGMENT RESULTS
The Company operates through strategic business units that are aggregated into four reportable segments: Cleaning, Household, Lifestyle and International.
·	Cleaning consists of laundry, home care and professional products marketed and sold in the United States. Products within this segment include laundry additives, including bleaches under the Clorox ® brand and Clorox 2 ® stain fighter and color booster; home care products, primarily under the Clorox ® , Formula 409 ® , Liquid-Plumr ® , Pine-Sol ® , S.O.S ® and Tilex ® brands; and naturally derived home care products under the Green Works ® brand.
	 
·	Household consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Products within this segment include plastic bags, wraps and containers, under the Glad ® brand; cat litter products under the Fresh Step ® , Scoop Away ® and Ever Clean ® brands; and charcoal products under the Kingsford ® and Match Light ® brands.
	 
·	Lifestyle consists of food products, water-filtration systems and filters marketed and sold in the United States and all natural personal care products. Products within this segment include dressings and sauces, primarily under the Hidden Valley ® and K C Masterpiece ® brands; water-filtration systems and filters under the Brita ® brand; and all natural personal care products under the Burt’s Bees ® and güd ™ brands.
	 
·	International consists of products sold outside the United States, excluding natural personal care products. Products within this segment include laundry, home care, water-filtration, charcoal and cat litter products, dressings and sauces, plastic bags, wraps and containers, and insecticides, primarily under the Clorox ® , Javex ® , Glad ® , PinoLuz ® , Ayudin ® , Limpido ® , Clorinda ® , Poett ® , Mistolin ® , Lestoil ® , Bon Bril ® , Nevex ® , Brita ® , Green Works ® , Pine-Sol ® , Agua Jane ® , Chux ® , Kingsford ® , Fresh Step ® , Scoop Away ® , Ever Clean ® , K C Masterpiece ® and Hidden Valley ® brands.
Certain nonallocated administrative costs, interest income, interest expense and various other nonoperating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, the Company’s headquarters and research and development facilities, information systems hardware and software, pension balances and other investments.
10

Table of Contents

NOTE 11. SEGMENT RESULTS (Continued)
The table below presents reportable segment information and a reconciliation of the segment information to the Company’s net sales and earnings (losses) from continuing operations before income taxes, with amounts that are not allocated to the operating segments reflected in Corporate.

		Net sales	
		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
Cleaning	     	$    	370		     	$    	354		     	$    	809		     	$    	803		
Household			334				320				700				674		
Lifestyle			230				218				444				419		
International			287				287				573				549		
Total Company		$	1,221			$	1,179			$	2,526			$	2,445		
 	
		Earnings (losses) from continuing
operations before income taxes	
		Three Months Ended		Six Months Ended	
		12/31/2011		12/31/2010		12/31/2011		12/31/2010	
Cleaning		$	78			$	64			$	186			$	185		
Household			34				25				76				78	 	
Lifestyle			70				(192	)			124				(134	)	
International			32			 	41	 		 	73	 			81		
Corporate		 	(59	)			(50	)			(117	)		 	(120	)	
Total Company		$	155			$	(112	)		$	342			$	90		

All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.
Net sales to the Company’s largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 26% for both the three and six months ended December 31, 2011, and 25% and 26% for the three and six months ended December 31, 2010, respectively.
For the three and six months ended December 31, 2010, the earnings (losses) from continuing operations before income taxes for the Lifestyle segment included a $258 non-cash goodwill impairment charge for the Burt’s Bees business.
NOTE 12. FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS
Accounting guidance on fair value measurements for certain financial assets and liabilities requires that financial assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
 Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
At December 31, 2011, the Company’s financial assets and liabilities that were measured at fair value on a recurring basis during the year included derivative financial instruments, which were all level 2.
Financial Risk Management and Derivative Instruments
The Company is exposed to certain commodity, interest rate and foreign currency risks relating to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.
11

Table of Contents
NOTE 12. FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Continued)
Commodity Price Risk Management
The Company may use commodity exchange traded futures and over-the-counter swap contracts to fix the price of a portion of its forecasted raw material requirements. Contract maturities, which are generally no longer than 18 months, are matched to the length of the raw material purchase contracts. Commodity purchase contracts are measured at fair value using market quotations obtained from commodity derivative dealers.
As of December 31, 2011, the net notional value of commodity derivatives was $34, of which $23 related to jet fuel, $8 related to soybean oil, and $3 related to crude oil. As of June 30, 2011, the net notional value of commodity derivatives was $44, of which $22 related to jet fuel, $16 related to soybean oil, $3 related to crude oil and $3 related to diesel fuel.
Interest Rate Risk Management
The Company may enter into over-the-counter interest rate forward contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate forward contracts generally have durations of less than six months. The interest rate contracts are measured at fair value using information quoted by U.S. government bond dealers. During the three months ended December 31, 2011, the Company paid $36 to settle interest rate forward contracts, which were reflected as operating cash outflows.
As of December 31, 2011 and June 30, 2011, the net notional value of interest rate forward contracts was $0 and $300.
Foreign Currency Risk Management
The Company may also enter into certain over-the-counter foreign currency-related derivative contracts to manage a portion of the Company’s foreign exchange risk associated with the purchase of inventory. These foreign currency contracts generally have durations no longer than twelve months. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.
As of December 31, 2011, the net notional values of outstanding foreign currency forward contracts related to the Company’s subsidiaries in Canada and Australia and used to hedge forecasted purchases of inventory were $19 and $13, respectively. As of June 30, 2011, the net notional values of outstanding foreign currency forward contracts related to the Company’s subsidiaries in Canada and Australia and used to hedge forecasted purchases of inventory were $28 and $13, respectively.
Counterparty Risk Management
Certain terms of the agreements governing the Company’s over-the-counter derivative instruments require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually defined counterparty liability position limits. As of December 31, 2011, no collateral was required to be posted.
Certain terms of the agreements governing the over-the-counter derivative instruments contain provisions that require the credit ratings, as assigned by Standard & Poor’s and Moody’s to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If our credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of December 31, 2011, the Company and each of its counterparties maintained investment grade ratings with both Standard & Poor’s and Moody’s.
Fair Value of Derivative Instruments
The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as a hedge, and on the type of the hedging relationship. For those derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument as a fair value hedge or a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts of forecasted purchases of inventory as cash flow hedges. During the three and six months ended December 31, 2011 and 2010, the Company had no hedging instruments designated as fair value hedges.
12

Table of Contents
NOTE 12. FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Continued)
The Company’s derivative financial instruments designated as hedging instruments are recorded at fair value in the condensed consolidated balance sheets as follows:

	     	Balance Sheet classification	     	12/31/2011	     	6/30/2011	
Assets									
Foreign exchange contracts	 	Other current assets		$	1		$	-	
Interest rate contracts		Other current assets			-			1	
Commodity purchase contracts		Other current assets			1		 	4	
			 	$	2	 	$	5	
 	
Liabilities									
Interest rate contracts		Accrued liabilities		$	-		$	1	
Commodity purchase contracts		Accrued liabilities			1			-	
				$	1		$	1	

For derivative instruments designated and qualifying as cash flow hedges, the effective portion of gains or losses is reported as a component of other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The estimated amount of the existing net loss at December 31, 2011, expected to be reclassified into earnings within the next twelve months is less than $1. Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. During the three and six months ended December 31, 2011 and 2010, hedge ineffectiveness was not material. The Company de-designates cash flow hedge relationships whenever it determines that the hedge relationships are no longer highly effective or that the forecasted transaction is no longer probable. The portion of gains or losses on the derivative instrument previously accumulated in OCI for de-designated hedges remains in accumulated OCI until the forecasted transaction is recognized in earnings, or is recognized in earnings immediately if the forecasted transaction is no longer probable.
The effects of derivative instruments designated as hedging instruments on OCI and on the condensed consolidated statements of earnings were as follows:

	     	Gain (loss) recognized in OCI	
		Three Months Ended		Six Months Ended	
	 	12/31/2011	     	12/31/2010	     	12/31/2011	     	12/31/2010	
Commodity purchase contracts		$          	2		 	$          	6		 	$          	-			$          	11		
Interest rate contracts		 	1			 	10				(36	)			6		
Foreign exchange contracts			(1	)			(2	)		 	2		 		(3	)	
Total		$	2			$	14			$	(34	)		$	14		
 	
		Gain reclassified from OCI and recognized in earnings	
	     	Three Months Ended		Six Months Ended	
		12/31/2011	     	12/31/2010	     	12/31/2011		12/31/2010	
Commodity purchase contracts		$          	1			$          	1			$          	2		     	$          	1		
Foreign exchange contracts			1				-				-				-		
Total		$	2			$	1			$	2			$	1		

13

Table of Contents
NOTE 12. FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Continued)
The gains reclassified from OCI and recognized in earnings during the three and six months ended December 31, 2011 and 2010, respectively, for commodity purchase contracts and foreign exchange contracts are included in cost of products sold.
Other
The carrying values of cash and cash equivalents, accounts receivable and accounts payable approximate their fair values at December 31, 2011 and June 30, 2011, due to the short maturity and nature of those balances. The estimated fair value of long-term debt, including current maturities, was $2,612 and $2,303 at December 31, 2011 and June 30, 2011, respectively. The fair value of long-term debt was determined using secondary market prices quoted by corporate bond dealers. The Company accounts for its long-term debt at face value, net of any unamortized discounts or premiums.
14

Table of Contents
 Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations
 The Clorox Company
 (Dollars in millions, except per share amounts)
Overview
The Clorox Company (the Company or Clorox) is a leading manufacturer and marketer of consumer and institutional products with approximately 8,100 employees worldwide as of December 31, 2011. The Company sells its products primarily through mass merchandisers, grocery stores and other retail outlets. Clorox markets some of consumers’ most trusted and recognized brand names, including its namesake bleach and cleaning products, Green Works ® naturally derived home care products, Pine-Sol ® cleaners, Poett ® home care products, Fresh Step ® cat litter, Kingsford ® charcoal, Hidden Valley ® and K C Masterpiece ® dressings and sauces, Brita ® water-filtration systems, Glad ® bags, wraps and containers, and Burt’s Bees ® and güd ™ natural personal care products. The Company manufactures products in more than two dozen countries and markets them in more than 100 countries.
The Company primarily markets its leading brands in midsized categories considered to have attractive economic profit potential. Most of the Company’s products compete with other nationally-advertised brands within each category and with “private-label” brands.
The Company operates through strategic business units that are aggregated into four reportable segments: Cleaning, Household, Lifestyle and International.
·	Cleaning consists of laundry, home care and professional products marketed and sold in the United States. Products within this segment include laundry additives, including bleaches under the Clorox ® brand and Clorox 2 ® stain fighter and color booster; home care products, primarily under the Clorox ® , Formula 409 ® , Liquid-Plumr ® , Pine-Sol ® , S.O.S ® and Tilex ® brands; and naturally derived home care products under the Green Works ® brand.
 
·	Household consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Products within this segment include plastic bags, wraps and containers, under the Glad ® brand; cat litter products under the Fresh Step ® , Scoop Away ® and Ever Clean ® brands; and charcoal products under the Kingsford ® and Match Light ® brands.
 
·	Lifestyle consists of food products, water-filtration systems and filters marketed and sold in the United States and all natural personal care products. Products within this segment include dressings and sauces, primarily under the Hidden Valley ® and K C Masterpiece ® brands; water-filtration systems and filters under the Brita ® brand; and all natural personal care products under the Burt’s Bees ® and güd ™ brands.
 
·	International consists of products sold outside the United States, excluding natural personal care products. Products within this segment include laundry, home care, water-filtration, charcoal and cat litter products, dressings and sauces, plastic bags, wraps and containers, and insecticides, primarily under the Clorox ® , Javex ® , Glad ® , PinoLuz ® , Ayudin ® , Limpido ® , Clorinda ® , Poett ® , Mistolin ® , Lestoil ® , Bon Bril ® , Nevex ® , Brita ® , Green Works ® , Pine-Sol ® , Agua Jane ® , Chux ® , Kingsford ® , Fresh Step ® , Scoop Away ® , Ever Clean ® , K C Masterpiece ® and Hidden Valley ® brands.
Certain nonallocated administrative costs, interest income, interest expense and various other nonoperating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, the Company’s headquarters and research and development facilities, information systems hardware and software, pension balances and other investments.
The following discussion of the Company’s financial condition and results of operations should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and Consolidated Financial Statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2011, which was filed with the Securities and Exchange Commission (SEC) on August 26, 2011, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q.
15

Table of Contents
Results of Operations
Management’s Discussion and Analysis of the Results of Operations, unless otherwise noted, is on a continuing operations basis and compares the three and six months ended December 31, 2011 (the current periods) to the three and six months ended December 31, 2010 (the prior periods) using percentages calculated on a rounded basis, except as noted. The Company has included the financial results of the sale of its global auto care businesses (Auto Businesses) in discontinued operations for the three and six months ended December 31, 2010. In addition, the discussion of results of operations of the Company as well as the Lifestyle segment includes certain financial measures that are not defined by accounting principles generally accepted in the United States of America (non-GAAP measures). These measures are, for the prior periods, diluted net earnings per share from continuing operations before non-cash goodwill impairment and earnings from continuing operations before income taxes and non-cash goodwill impairment. The Company’s management uses these non-GAAP measures to evaluate business performance and believes that they provide investors with additional information about the underlying results and trends of the Company. These non-GAAP financial measures may not be the same as similar measures presented by other companies. Analyses of these non-GAAP measures are set forth in the diluted net earnings (losses) per share from continuing operations and Lifestyle segment results sections below.
CONSOLIDATED RESULTS FROM CONTINUING OPERATIONS
Diluted net earnings (losses) per share from continuing operations
The following is a reconciliation of diluted net earnings (losses) per share from continuing operations to diluted net earnings per share from continuing operations before the non-cash goodwill impairment charge recognized in the prior quarter:

	     	Three Months Ended		Six Months Ended	
		12/31/2011	     	12/31/2010	     	12/31/2011	     	12/31/2010	
Net earnings (losses) per share from continuing operations	 	$     	0.79	 	$     	(1.17	)	 	$     	1.76		$     	(0.17	)	
Add back: Non-cash goodwill impairment per share		 	-		 	1.85	 			-	 	 	1.85		
Net earnings per share from continuing operations before															
       non-cash goodwill impairment		$	0.79		$	0.68			$	1.76		$	1.68		

Excluding the non-cash goodwill impairment charge recognized in the prior quarter, the Company’s diluted net earnings per share from continuing operations increased $0.11 and $0.08 in the current periods, respectively. These increases were primarily due to the benefit of price increases and cost savings, partially offset by higher commodity costs, primarily resin, and higher manufacturing and logistics costs. Also contributing to the increases in the current periods were lower weighted average shares outstanding, primarily due to share repurchase activities.
16

Table of Contents
		Three Months Ended				% of Net sales	
	     	12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	
Net sales		$      	1,221		$      	1,179	 	           4	%		         100.0	%		      100.0	%	
Gross profit	 		507	 	 	492		3		 	41.5		 	41.7		
Selling and administrative expenses		 	184			180		2	 		15.1	 		15.3		
Advertising costs			115			117		(2	)		9.4			9.9	 	
Research and development costs			29			28		4			2.4			2.4		
 	
		Six Months Ended					% of Net sales	
		12/31/2011		12/31/2010		% Change		12/31/2011		12/31/2010	
Net sales		$	2,526		$	2,445		3	%		100.0	%		100.0	%	
Gross profit			1,053			1,053		-			41.7			43.1		
Selling and administrative expenses			374			361		4			14.8			14.8		
Advertising costs			233			235		(1	)		9.2			9.6		
Research and development costs			57			57		-			2.3			2.3		

Net sales increased while volume remained flat in the current quarter. Net sales and volume increased in the current six month period.
Flat volume in the current quarter reflected higher shipments in Argentina, higher shipments of Clorox ® disinfecting bathroom cleaner, higher shipments of Fresh Step ® cat litter behind new product innovation and higher shipments of the new Brita ® on-the-go water bottle. These increases were offset by lower shipments in the nonstrategic export business , lower shipments of Clorox ® liquid bleach due to price increases and lower shipments of Clorox ® disinfecting wipes. Net sales growth outpaced volume primarily due to the benefit of price increases (approximately 510 basis points), partially offset by unfavorable mix (approximately 100 basis points).
Volume growth of 1% in the current six month period was primarily driven by higher shipments of Fresh Step ® and Scoop Away ® cat litter behind new product innovation; higher shipments of Clorox ® disinfecting bathroom cleaner; higher shipments of Burt’s Bees ® natural personal care products, primarily due to new products; higher shipments in Argentina; and higher shipments of the new Brita ® on-the-go water bottle. These increases were partially offset by lower shipments of Clorox ® liquid bleach, primarily due to price increases; lower shipments in the nonstrategic export business ; lower shipments of Glad ® base trash bags due to price increases; and lower shipments of Brita ® pour-through water-filtration products. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 440 basis points), partially offset by unfavorable mix (approximately 150 basis points).
17

Gross margin , defined as gross profit as a percentage of net sales, decreased in the current periods. Gross margin decline in the current quarter was primarily driven by approximately 240 basis points from higher commodity costs, approximately 170 basis points from higher manufacturing and logistics costs and approximately 90 basis points from unfavorable mix. These factors were partially offset by approximately 240 basis points from the benefit of price increases and approximately 180 basis points from the benefit of cost savings.
Gross margin decline in the current six month period was primarily driven by approximately 290 basis points from higher commodity costs, approximately 170 basis points from higher manufacturing and logistics costs and approximately 80 basis points from unfavorable mix. These factors were partially offset by approximately 200 basis points from the benefit of price increases and approximately 160 basis points from the benefit of cost savings.
Selling and administrative expenses increased in the current quarter, primarily due to higher infrastructure investments in information systems and facilities and higher long-term employee incentive compensation costs, partially offset by cost savings.
Selling and administrative expenses increased in the current six month period, primarily due to advisory fees related to a withdrawn proxy contest in the quarter ended September 30, 2011.
Advertising costs decreased as a percentage of sales during the current periods, primarily driven by reduced media spending.
Research and development costs remained flat as a percentage of net sales for the current periods as the Company continues to support its new products and established brands with an emphasis on innovation.
Interest expense decreased by $3 and $6, in the current periods, respectively, primarily due to a decline in average long-term debt balances.
Other income, net, was $6 and $12 in the current periods , respectively, and $12 and $13 in the prior periods , respectively . Other income, net, in the current quarter included $4 of equity in earnings of unconsolidated affiliates and $2 of income from transition services related to the Company’s sale of its Auto Businesses. Other income, net, in the prior quarter included gains on asset sales.
Other income, net, in the current six month period included $6 of equity in earnings of unconsolidated affiliates and $4 of income from transition services related to the Company’s sale of its Auto Businesses. Other income, net, in the prior six month period included gains on asset sales.
18

Table of Contents
The effective tax rate on earnings (losses) from continuing operations was 32.4% and 31.3% for the current periods, respectively, and (45.0)% and 125.9% for the prior periods, respectively. The tax rates for the current periods include tax benefits associated with foreign earnings and from favorable tax settlements. The substantially different tax rates for the prior periods resulted from the non-deductible non-cash goodwill impairment charge of $258 related to the Burt’s Bees reporting unit as there was no substantial tax benefit associated with this non-cash charge.
SEGMENT RESULTS FROM CONTINUING OPERATIONS
The following presents the results from continuing operations of the Company’s reportable segments and certain unallocated costs reflected in Corporate:
CLEANING

	     	Three Months Ended					Six Months Ended				
		12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	     	% Change	
Net sales	 	$     	370	 	$     	354		          5	%	 	$     	809	 	$     	803		          1	%	
Earnings from continuing operations		 					 	 				 		 	 				
       before income taxes			78			64		22				186			185	 	1		

Net sales and earnings from continuing operations before income taxes increased while volume remained flat in the current quarter. In the current six month period, net sales and earnings from continuing operations increased while volume decreased.
Flat volume in the current quarter reflected higher shipments in the Away From Home business and higher shipments of Clorox ® disinfecting bathroom cleaner, primarily due to new product innovation; offset by lower shipments of Clorox ® liquid bleach due to price increases and lower shipments of Clorox ® disinfecting wipes. Net sales growth outpaced volume primarily due to the benefit of price increases (approximately 530 basis points), partially offset by unfavorable mix (approximately 110 basis points). The increase in earnings from continuing operations before income taxes was primarily due to $16 of higher net sales and $6 of cost savings due to various manufacturing efficiencies. These increases were partially offset by $9 of higher commodity costs, primarily resin.
Volume decline of 1% in the current six month period was primarily driven by lower shipments of Clorox ® laundry additives due to price increases, partially offset by higher shipments of Clorox ® disinfecting bathroom cleaner and higher shipments in the Away From Home business. The variance between net sales growth and volume decline was primarily due to the benefit of price increases (approximately 360 basis points), partially offset by unfavorable mix (approximately 170 basis points). The increase in earnings from continuing operations before income taxes was primarily due to $13 of cost savings due to various manufacturing efficiencies, $8 of lower advertising and sales promotion expenses and $6 of higher net sales. These increases were partially offset by $20 of higher commodity costs, primarily resin, and $7 of higher manufacturing and logistics costs.
HOUSEHOLD

	     	Three Months Ended					Six Months Ended				
		12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	     	% Change	
Net sales	 	$     	334	 	$     	320	 	          4	%	 	$     	700		$     	674	 	          4	%	
Earnings from continuing operations		 			 			 	 				 	 	 				
       before income taxes			34			25		36				76			78		(3	)	

Net sales, volume and earnings from continuing operations before income taxes increased in the current quarter. In the current six month period, net sales and volume increased while earnings from continuing operations before income taxes decreased.
19

Table of Contents
Volume growth of 1% in the current quarter was primarily due to higher shipments of Fresh Step ® and Scoop Away ® cat litter driven by new product innovation, partially offset by lower shipments of Glad ® food storage products and base trash bags due to price increases. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 460 basis points), partially offset by unfavorable mix (approximately 140 basis points). The increase in earnings from continuing operations before income taxes was primarily due to $14 of higher net sales and $8 of cost savings due to various manufacturing efficiencies. These increases were partially offset by $11 of higher commodity costs, primarily resin.
Volume growth of 3% in the current six month period was primarily driven by higher shipments of Fresh Step ® and Scoop Away ® cat litter, driven by new product innovation and higher shipments of Kingsford ® charcoal due to higher merchandising partially offset by lower shipments of Glad ® base trash bags due to price increases. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 460 basis points), partially offset by unfavorable mix (approximately 160 basis points). The decrease in earnings from continuing operations before income taxes was primarily due to $28 of higher commodity costs, primarily resin, and $14 of higher manufacturing and logistics costs. These decreases were partially offset by $26 of higher sales and $16 of cost savings due to various manufacturing efficiencies.
LIFESTYLE

		Three Months Ended					Six Months Ended				
	     	12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	     	% Change	
Net sales		$     	230		$     	218			            6	%		$     	444		$     	419			            6	%	
Earnings (losses) from continuing		 								 	 							 			
       operations before income taxes	 		70		 	(192	)		136				124		 	(134	)		193		
Non-cash goodwill impairment			-	 		258			(100	)			-	 		258			(100	)	
Earnings from continuing operations			 			 	 		 			 									
       before income taxes and non-cash								 													
       goodwill impairment		$	70		$	66			6	%		$	124		$	124			-	%	

Refer to Results of Operations introductory paragraph above and analysis below for information about earnings from continuing operations before income taxes and non-cash goodwill impairment, a non-GAAP measure.
Net sales and volume increased in the current periods . Earnings from continuing operations before income taxes and non-cash goodwill impairment increased and remained flat in the current periods, respectively.
Volume growth of 2% in the current quarter was primarily driven by higher shipments of the new Brita ® on-the-go water bottle and higher shipments of Burt’s Bees ® natural personal care products, primarily due to new products. These increases were partially offset by lower shipments of K C Masterpiece ® barbeque sauce, primarily due to competitive activity. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 400 basis points) and favorable mix (approximately 70 basis points), partially offset by trade promotion spending (approximately 80 basis points). The increase in earnings from continuing operations before income taxes and the non-cash goodwill impairment charge was primarily due to $12 of higher net sales.
Volume growth of 4% in the current six month period was primarily driven by higher shipments of Burt’s Bees ® natural personal care products, primarily due to new products, and higher shipments of the new Brita ® on-the-go water bottle and Hidden Valley ® salad dressings. These increases were partially offset by lower shipments of Brita ® pour-through water-filtration products. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 340 basis points), partially offset by trade promotion spending (approximately 90 basis points). Earnings from continuing operations before income taxes and the non-cash goodwill impairment charge remained flat, and reflected $25 of higher net sales; offset by $10 of higher commodity costs, primarily soybean oil, and $6 of higher advertising and sales promotion in support of new product launches.
20

Table of Contents
INTERNATIONAL

	     	Three Months Ended					Six Months Ended				
	 	12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	     	% Change	
Net sales		$     	287	 	$     	287	 	           -	%	 	$     	573		$     	549		           4	%	
Earnings from continuing operations													 			 			
       before income taxes			32			41		(22	)			73			81		(10	)	

Net sales remained flat, volume declined and earnings from continuing operations before income taxes decreased in the current quarter. Net sales and volume increased while earnings from continuing operations before income taxes decreased in the current six month period.
Volume decline of 1% in the current quarter was primarily driven by lower shipments in the nonstrategic export business and Venezuela. These decreases were partially offset by higher shipments in Argentina and Europe . Sales were flat, as the benefit of price increases (approximately 630 basis points) was offset by unfavorable foreign currency exchange rates (approximately 230 basis points), unfavorable mix (approximately 160 basis points) and trade promotion spending (approximately 110 basis points). The decrease in earnings from continuing operations before income taxes was primarily driven by $10 of higher manufacturing and logistics costs and other smaller items, partially offset by $18 from the benefit of price increases.
Volume growth of 1% in the current six month period was primarily due to higher shipments in Argentina and distribution gains in a number of small emerging countries in Asia and the Middle East. These increases were partially offset by lower shipments in the nonstrategic export business and Venezuela, and lower shipments of Glad ® products in Canada due to category softness. Net sales growth outpaced volume growth primarily due to the benefit of price increases (approximately 620 basis points), partially offset by unfavorable mix (approximately 240 basis points) and trade promotion spending (approximately 80 basis points). The decrease in earnings from continuing operations before income taxes was primarily due to $18 of higher manufacturing and logistics costs, primarily related to inflationary pressures in Argentina and Venezuela; $12 of higher commodity costs, primarily resin; $11 of higher selling and administrative expenses associated with investments in information systems infrastructure and inflationary pressures in Argentina and Venezuela; and $7 of unfavorable mix. These decreases were partially offset by $34 from the benefit of price increases and $7 of cost savings, primarily related to various manufacturing efficiencies.
CORPORATE

		Three Months Ended					Six Months Ended				
	     	12/31/2011	     	12/31/2010	     	% Change	     	12/31/2011	     	12/31/2010	     	% Change	
Losses from continuing operations							 			 			 			 			
       before income taxes		$     	59		$     	50		         18	%		$     	117		$     	120		         (3	)%	

The increase in losses from continuing operations before income taxes attributable to Corporate in the current quarter was primarily due to gains on asset sales recognized in the prior quarter.
The decrease in losses from continuing operations before income taxes attributable to Corporate in the current six month period was primarily due to lower information technology expenses reflected in Corporate; lower employee benefit and incentive compensation expenses; and lower interest expense, primarily due to a decline in average long-term debt balances. These factors were partially offset by gains on asset sales in the prior six month period and fees related to a withdrawn proxy contest in the current six month period.
21

Table of Contents
Financial Condition, Liquidity and Capital Resources
Operating Activities
The Company’s financial condition and liquidity remain strong as of December 31, 2011. Net cash provided by continuing operations was $168 for the current six month period, compared with $170 in the prior six month period.
Investing Activities
Capital expenditures were $82 in the current six month period, compared with $89 in the prior six month period. Capital spending as a percentage of net sales was 3.2% in the current six month period, compared with 3.6% in the prior six month period. The slight decrease was primarily associated with a shift in the timing of spending for the implementation of the Company’s investments in global information technology systems and manufacturing and infrastructure improvements.
On December 31, 2011, the Company acquired HealthLink, Inc., Aplicare, Inc. and Soy Vay Enterprises, Inc. for purchase prices aggregating $97. The Company paid $85 during the current quarter, funded through commercial paper borrowings. The amount paid reflects the aggregate purchase prices reduced by the cash acquired and amounts to be paid by the Company pending final cash settlements. HealthLink, based in Jacksonville, Fla., and Aplicare, based in Meriden, Conn., are leading providers of infection control products for the health care industry, complementing and expanding the Company’s Away From Home health care business. Results for these businesses will be reflected in the Cleaning reportable segment. Soy Vay Enterprises, a California-based operation, provides the Company’s Food business a presence in the growing market for Asian sauces. Results for this business will be reflected in the Lifestyle reportable segment.
Financing Activities
In November 2011, the Company filed a new shelf registration statement with the SEC, which allows the Company to offer and sell an unlimited amount of its senior unsecured indebtedness from time to time. The shelf registration statement will expire in November 2014. Subsequently, the Company issued $300 of senior notes (notes) under the new shelf registration statement. The notes carry an annual fixed interest rate of 3.80% payable semi-annually in May and November. The notes mature on November 15, 2021. Proceeds from the notes were used to retire commercial paper. The notes rank equally with all of the Company’s existing and future senior indebtedness.
Net cash provided by financing activities was $ 38 in the current six month period, as compared to a $622 net cash outflow in the prior six month period. The increase in net cash provided by financing activities was primarily due to the use of proceeds from the sale of the Auto Businesses to repay commercial paper in the prior six month period.
At December 31, 2011 and June 30, 2011, the Company had $463 and $456, respectively, of commercial paper outstanding at a weighted average interest rate of 0.47% and 0.33%, respectively. The average commercial paper outstanding was $451 for both the three and six months ended December 31, 2011, at a weighted average interest rate of 0.36% and 0.38%, respectively. The average commercial paper outstanding for the three and six months ended December 31, 2010 was $283 and $356 at a weighted average interest rate of 0.41% and 0.43%, respectively.
Credit Arrangements
At December 31, 2011, the Company had a $1.1 billion revolving credit agreement with an expiration date of April 2013. There were no borrowings under this revolving credit agreement, which the Company believes is available and will continue to be available for general corporate purposes and to support commercial paper issuances. The revolving credit agreement includes certain restrictive covenants. The primary restrictive covenant is a maximum ratio of total debt to earnings before interest, taxes, depreciation and amortization and other items (EBITDA) for the trailing four quarters (EBITDA ratio), as defined in the Company’s revolving credit agreement, of 3.25. EBITDA, as defined, may not be comparable to similarly titled measures used by other entities.
22

Table of Contents
The following table sets forth the calculation of the EBITDA ratio at December 31, using EBITDA for the trailing four quarters, as contractually defined:

	     	2011	     	2010	
Net earnings		$     	555			$     	573		
Add back:									
       Interest expense			117				131		
       Income tax expense			260				395		
       Depreciation and amortization			174				178		
       Goodwill impairment charge			-				258		
Deduct:									
       Interest income			(3	)			(3	)	
       Gain on sale			-	 	 		(326	)	
EBITDA	 	$	1,103			$	1,206		
Total debt		$	2,896			$	2,428		
EBITDA ratio			2.63				2.01		
The Company is in compliance with all restrictive covenants and limitations as of December 31, 2011. The Company anticipates being in compliance with all restrictive covenants for the foreseeable future. The Company continues to monitor the financial markets and assess its ability to fully draw under its revolving credit facility, but currently expects that any drawing on the facility will be fully funded.
The Company had $41 of foreign and other credit lines at December 31, 2011, of which $27 was available for borrowing.
Share Repurchases
The Company has three share repurchase programs: two open-market purchase programs and a program to offset the impact of share dilution related to share-based awards (the Evergreen Program). In May 2008, the Company’s board of directors approved an open-market purchase program with a total authorization of $750, of which $71 remains available as of December 31, 2011. In May 2011, the board of directors approved a second open-market purchase program with a total authorization of $750, all of which remains available as of December 31, 2011. The Evergreen Program has no authorization limit as to amount or timing of repurchases. The purpose of the Evergreen Program is to offset the impact of share dilution related to share-based awards.
Share repurchases under authorized programs were as follows:

	     	Three Months Ended		Six Months Ended	
		12/31/2011	     	12/31/2010	     	12/31/2011	     	12/31/2010	
		Amount	     	Shares
(000)		Amount	     	Shares
(000)	 	Amount	     	Shares
(000)		Amount	     	Shares
(000)	
Open-market purchase programs		$     	149	 	       2,300		$     	-	 	-		$     	158		       2,429		$     	-	 	-	
Evergreen Program	 		-		-	 	 	130		       2,063			-	 	-	 	 	134		       2,121	
Total		$	149		2,300		$	130		2,063		$	158		2,429		$	134		2,121	

23

Table of Contents
Contingencies
The Company is involved in certain environmental matters, including Superfund and other response actions at various locations. The Company had a recorded liability of $15 at both December 31, 2011 and June 30, 2011, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson County, Michigan, for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability at both December 31, 2011 and June 30, 2011. The Company has agreed to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company cannot accurately predict the timing of future payments that may be made under this obligation. In addition, the Company’s estimated loss exposure is sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes in remediation requirements and the timing, varying costs and alternative clean-up technologies that may become available in the future. Although it is possible that the Company’s exposure may exceed the amount recorded, any amount of such additional exposures, or range of exposures, is not estimable at this time.
The Company is subject to various other lawsuits and claims relating to issues such as contract disputes, product liability, patents and trademarks, advertising, and employee and other matters. Based on the Company’s analysis of these claims and litigation, it is the opinion of management that the ultimate disposition of these matters, including the environmental matter described above, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on the Company’s consolidated financial statements taken as a whole.
Off - Balance Sheet Arrangements
In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) for which terms vary in duration and potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make any payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material effect on its financial position, results of operations or cash flows, either individually or in the aggregate.
At December 31, 2011, the Company was a party to letters of credit of $15, primarily related to one of its insurance carriers.
The Company had not recorded any liabilities on any of the aforementioned off - balance sheet arrangements at December 31, 2011.
24

Table of Contents
Cautionary Statement
This Quarterly Report on Form 10-Q (this Report), including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and such forward-looking statements involve risks and uncertainties. Except for historical information, matters discussed below, including statements about future volume, sales, costs, cost savings, earnings, cash flows, plans, objectives, expectations, growth, or profitability, are forward-looking statements based on management’s estimates, assumptions and projections. Words such as “will,” “could,” “may,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and variations on such words, and similar expressions, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed below. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated from time to time in the Company’s Securities and Exchange Commission (SEC) filings. These factors include, but are not limited to the Company’s costs, including volatility and increases in commodity costs such as resin, diesel, chlor-alkali, sodium hypochlorite, high-strength bleach, agricultural commodities and other raw materials; increases in energy costs; the ability of the Company to implement and generate expected savings from its programs to reduce costs, including its supply chain restructuring and other restructuring plans; supply disruptions or any future supply constraints that may affect key commodities or product inputs; risks inherent in relationships with suppliers, including sole-source or single-source suppliers; risks related to the handling and/or transportation of hazardous substances, including, but not limited to, chlorine; the success of the Company’s strategies; the ability to manage and realize the benefits of joint ventures and other cooperative relationships, including the Company’s joint venture regarding the Company’s Glad ® plastic bags, wraps and containers business, and the agreements relating to the provision of information technology, procure to pay and other key services by third parties; risks relating to acquisitions, mergers and divestitures, and the costs associated therewith; risks inherent in maintaining an effective system of internal controls, including the potential impact of acquisitions or the use of third-party service providers, and the need to refine controls to adjust for accounting, financial reporting and other organizational changes or business conditions; the ability of the Company to successfully manage tax, regulatory, product liability, intellectual property, environmental and other legal matters, including the risk resulting from joint and several liability for environmental contingencies and risks inherent in litigation, including class action litigation; risks related to maintaining and updating the Company’s information systems, including potential disruptions, costs and the ability of the Company to implement adequate information systems in order to support the current business and to support the Company’s potential growth; the ability of the Company to develop commercially successful products that delight the consumer; consumer and customer reaction to price changes; actions by competitors; risks related to customer concentration; customer-specific ordering patterns and trends; risks arising out of natural disasters; the impact of disease outbreaks, epidemics or pandemics on the Company’s, suppliers’ or customers’ operations; changes in the Company’s tax rate; unfavorable worldwide, regional or local general economic and marketplace conditions and events, including consumer confidence and consumer spending levels, the rate of economic growth, the rate of inflation or deflation, and the financial condition of the Company’s customers, suppliers and service providers; foreign currency exchange rate fluctuations and other risks of international operations; unfavorable political conditions in the countries where the Company does business and other operational risks in such countries; the impact of the volatility of the debt and equity markets on the Company’s cost of borrowing, cost of capital and access to funds, including commercial paper and the Company’s credit facility; risks relating to changes in the Company’s capital structure, including risks related to the Company’s ability to implement share repurchase plans and the impact thereof on the Company’s capital structure and earnings per share; the impact of any unanticipated restructuring or asset-impairment charges and the ability of the Company to successfully implement restructuring plans; risks arising from declines in cash flow, whether resulting from declining sales, higher cost levels, tax payments, debt payments, share repurchases, higher capital spending, interest cost increases greater than management’s expectations, interest rate fluctuations, increases in debt or changes in credit ratings, or otherwise; the costs and availability of shipping and transport services; potential costs in the event of stockholder activism; and the Company’s ability to maintain its business reputation and the reputation of its brands.
The Company’s forward-looking statements in this Report are based on management’s current views and assumptions regarding future events and speak only as of their dates. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
In this Report, unless the context requires otherwise, the terms “the Company” and “Clorox” refer to The Clorox Company and its subsidiaries.
25

Table of Contents
 Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have not been any material changes to the Company’s market risk during the quarter ended December 31, 2011, except as described in the Management’s Discussion and Analysis of Financial Condition and Results of Operations in this Report. For additional information, refer to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.
Item 4. Controls and Procedures
The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding disclosure.
26

Table of Contents
PART II – OTHER INFORMATION
Item 1.A. Risk Factors
For information regarding Risk Factors, please refer to Item 1.A. in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.
 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table sets forth the purchases of the Company’s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the second quarter of fiscal year 2012.

 	         	(a)	         	[b]	         	[c]	         	[d]	
Period	 	Total Number of
Shares Purchased(1)	 	Average Price Paid
per Share	 	Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs	 	Approximate Dollar Value of
Shares that May Yet
Be Purchased Under the
Plans or Programs(2)	
October 1 to 31, 2011	 	9,392	 	$	68.01	 	-	 	$	970,168,450	
November 1 to 30, 2011	 	2,111,205	 		64.83	 	2,110,387	 		833,356,652	
December 1 to 31, 2011	 	189,161	 		65.16	 	189,161	 		821,030,117	
Total	 	2,309,758	 		64.87	 	2,299,548	 		821,030,117	
____________________
 
(1)		The total shares purchased in October 2011 relate to the surrender to the Company of shares of common stock to satisfy tax withholding obligations in connection with the distribution of performance units. Of the shares purchased in November 2011, 2,110,387 shares were acquired pursuant to the Company’s $750,000,000 open-market purchase program approved on May 13, 2008. The remaining 818 shares relate to the surrender to the Company of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted shares and the distribution of performance units. The total shares purchased in December 2011 were acquired pursuant to the Company’s $750,000,000 open-market purchase program approved on May 13, 2008.	
	     		
(2)		As of December 31, 2011, all of the $750,000,000 share repurchase program approved by the board of directors on May 18, 2011, remained available for repurchase, and $71,030,117 of the $750,000,000 share repurchase program approved by the board of directors on May 13, 2008, remained available for repurchase. On September 1, 1999, the Company announced a share repurchase program to reduce or eliminate dilution upon the issuance of shares pursuant to the Company’s stock compensation plans. The program initiated in 1999 has no specified cap and therefore is not included in column [d] above. On November 15, 2005, the board of directors approved the extension of the 1999 program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company’s 2005 Stock Incentive Plan. None of these programs has a specified termination date.	
Item 5. Other Information
On November 16, 2011, at the Company’s annual meeting of stockholders, in a non-binding vote of the Company’s stockholders regarding the frequency of holding future advisory votes on executive compensation, the proposed frequency that received the highest number of votes was every one year. In light of this result and the other factors considered by the Company’s board of directors in making its original recommendation to the stockholders, the Company will hold a non-binding advisory vote on executive compensation every year until the Company’s board of directors determines that a different frequency for such advisory vote is in the Company’s best interest or the next required vote in six years on the frequency of such advisory vote.
27

Table of Contents
 Item 6. Exhibits

31.1	Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	
          		
31.2	Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	
 	
32	Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 		
101	The following materials from The Clorox Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2011 are formatted in eXtensible Business Reporting Language (XBRL): (i) Condensed Consolidated Statements of Earnings, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements.	
28

Table of Contents
S I G N A T U R E
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			THE CLOROX COMPANY
 (Registrant)	

DATE: February 6, 2012	BY	      	/s/ Susan A. Gentile	 	
 	 	 	Susan A. Gentile	
 	 	 	Vice President – Controller and	
 	 	 	Principal Accounting Officer	

29

Table of Contents
EXHIBIT INDEX

Exhibit No.	
	 	
31.1	Certification by the Chief Executive Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	
          		
31.2	Certification by the Chief Financial Officer of the Company Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	
 	
32	Certification by the Chief Executive Officer and Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	
101	The following materials from The Clorox Company’s Quarterly Report on Form 10-Q for the period ended December 31, 2011 are formatted in eXtensible Business Reporting Language (XBRL): (i) Condensed Consolidated Statements of Earnings, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements.	
30

Exhibit 31.1
CERTIFICATION

	I, Donald R. Knauss, certify that:	
	 	
1.	I have reviewed this quarterly report on Form 10-Q of The Clorox Company;	
 		
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;	
 	
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;	
 	
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:	
       	       		
	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;	
 	
	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;	
 	
	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and	
 	
	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.	
 	
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):	
 	
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and	
 	
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.	
Date: February 6, 2012

/s/ Donald R. Knauss	
Donald R. Knauss	
Chairman and Chief Executive Officer	

Exhibit 31.2
CERTIFICATION

	I, Stephen M. Robb, certify that:	
	 	
1.	I have reviewed this quarterly report on Form 10-Q of The Clorox Company;	
 		
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;	
 	
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;	
 	
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:	
       	       		
	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;	
 	
	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;	
 	
	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and	
 	
	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.	
 	
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):	
 	
	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and	
 	
	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.	
Date: February 6, 2012

/s/ Stephen M. Robb	
Stephen M. Robb	
Senior Vice President - Chief Financial Officer	

Exhibit 32
CERTIFICATION
In connection with the periodic report of The Clorox Company (the "Company") on Form 10-Q for the period ended December 31, 2011, as filed with the Securities and Exchange Commission (the "Report"), we, Donald R. Knauss, Chief Executive Officer of the Company, and Stephen M. Robb, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:

 	(1)	 	the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and	
     		     		
 	(2)	 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.	
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
Date: February 6, 2012

/s/ Donald R. Knauss	
Donald R. Knauss	
Chairman and Chief Executive Officer	

/s/ Stephen M. Robb	
Stephen M. Robb	
Senior Vice President – Chief Financial Officer